On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name Spravato) nasal spray as a "monotherapy" treatment for major ...

For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).

The FDA has approved Janssen’s antidepressant ... who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...

Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the Food and Drug Administration (FDA) to treat the following conditions in adults: Spravato is a brand ...

Janssen’s potential depression treatment made from esketamine – a version of the substance notoriously used illegally as a party drug – is to be reviewed by advisers to the FDA at a crunch ...

Esketamine does of 56 and 84 mg with comprehensive standard-of-care rapidly improved depressive symptoms in adolescents at risk for suicide.

There is hope for your symptoms. The clinic also offer the FDA approved Spravato (Esketamine) for treatment resistant depression, anxiety, and PTSD. Call for inquiries. Immediate appointment times ...